TGM2 and Huntington disease: Interesting work done by Kim et al., has shown that transglutaminase 2 has inhibitory effect on Aco2 activity, contributing to aggregates of Aco2 and that increased transglutaminase activity in the striatum of human HD may be the underlying cause of the reported reduced Aco2 activity in the striatum of HD [39].